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ARTICLE
Differential effects of the APOE e4 allele on different
domains of cognitive ability across the life-course
Riccardo E Marioni*,1,2,3, Archie Campbell2, Generation Scotland4, Caroline Hayward5, David J Porteous1,2 and
Ian J Deary1,6
The association between APOE genotype and cognitive function suggests a positive role for the e2 allele and a negative role for
the e4 allele. Both alleles have relatively low frequencies in the general population; hence, meta-analyses have been based on
many small, heterogeneous studies. Here, we report the APOE-cognition associations in the largest single analysis to date. APOE
status and cognitive ability were measured in 18 337 participants from the Generation Scotland study between 2006 and 2011.
The age range was 18–94 years with a mean of 47 (SD 15). Four cognitive domains were assessed: verbal declarative memory
(paragraph recall), processing speed (digit symbol substitution), verbal ﬂuency (phonemic verbal ﬂuency), and vocabulary
(Mill Hill synonyms). Linear regression was used to assess the associations between APOE genetic status and cognition.
Possession of the e4 allele was associated with lower scores on the measures of memory and processing speed in subjects aged
460. Across all age ranges, the e4 allele was linked to better verbal ﬂuency scores. In younger subjects (≤60 years) the e4
allele was linked to higher vocabulary scores. There were no associations between the e2 allele and cognitive ability. As seen in
previous meta-analyses, the APOE e4 allele is linked to poorer cognitive performance in the domains of memory and processing
speed. By contrast, positive associations were seen between the e4 allele and measures of verbal ﬂuency and vocabulary.
All associations were relatively small and, in many cases, nominally signiﬁcant despite the very large sample size.
European Journal of Human Genetics advance online publication, 23 September 2015; doi:10.1038/ejhg.2015.210
INTRODUCTION
The association between Alzheimer's disease (AD) and the APOE e4
allele is well established. It is estimated that individuals who carry two
copies of the e4 allele have more than 10 times the risk of developing
the late-onset version of the disease.1 Although AD typically manifests
in older individuals, it is also of interest to investigate the association
between APOE and cognitive ability across the life-course. Studies have
indicated a link between the e4 allele and both lower ability2 and
increased cognitive decline,3,4 although this is not always the case.5
Conversely, the e2 allele is thought to be protective for AD,6 and has
been associated with longevity and survival in the oldest old.7
However, a recent large study (total n= 2013) of APOE genotype
and cognitive decline found no association between either e2 or e4
status and cognitive change in ﬁve different tests, even when split by
age group.8 However, the low frequency of both the e2 and e4 alleles
(6% and 15%, respectively in the general population9) means that
these results are based on relatively small numbers.
To provide a more deﬁnitive summary of the relationship between
APOE and cognitive ability requires either a meta-analytic approach2,4
or the analysis of extremely large populations. A previous meta-
analysis containing over 40 000 people showed a negative cross-
sectional association between the e4 allele and measures of episodic
memory, executive function, perceptual speed, and global cognitive
ability.2 The analysis data came from 77 studies where the largest
sample size was 7895, with only eight cohorts having a sample size
41000. However, 34 cohorts had fewer than 100 participants. In
addition to the heterogeneity of these populations, there were also
differences with the phenotypic measurement as different tests were
used to assess the domains under investigation, not all of which were
present in all studies. Moreover, there was reduced power to
investigate APOE zygosity effects and effects of the e2 allele on
memory and global ability, with information only available from a
maximum of six studies. Age moderation was seen for the domains of
episodic memory and global ability, where the negative effect of the e4
allele was more pronounced in older individuals.
Here we overcome the issues of phenotypic and population
heterogeneity, and small sample sizes with respect to zygosity and e2
analyses by examining the association between APOE and cognitive
function in an ethnically and culturally homogeneous sample of
18 337 subjects, aged between 18 and 94 years from the Generation
Scotland: Scottish Family Health Study.
MATERIALS AND METHODS
Data came from Generation Scotland: the Scottish Family Health Study (GS:
SFHS), which is a family-based cohort study sampled from the general
population in Scotland (www.generationscotland.org/). Details of the study
design have been reported previously.10,11 In brief, over 24 000 subjects were
recruited into the study between 2006 and 2011. The initial sample of probands
(n= 7953) were registered with general medical practitioners from ﬁve regions
of Scotland, and aged between 35 and 65 years. Ascertainment was unbiased, ie,
there was no recruitment drive to obtain individuals with any particular
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disorder. Probands' relatives were recruited to yield the full GS:SFHS sample
(age range 18–99). There were up to three generations per family with 5628
families and 1395 singleton participants. In the current analysis we only
considered individuals who had both APOE and cognitive data on at least one
test available (n= 18 337).
Genotyping sample
APOE haplotype status depends on the genotypes of two single-nucleotide
polymorphisms, rs429358 (hg19 chr19:g.45411941T4C) and rs7412 (hg19
chr19:g.45412079C4T). These two single-nucleotide polymorphisms can form
three possible haplotypes: e2=hg19 chr19:g.[45411941T= ;45412079C4T]
(rs429358 T and rs7412 T), e3=hg19 chr19:g.[45411941T= ;45412079C= ]
(rs429358 T and rs7412 C) and e4=hg19 chr19:g.[45411941T4C= ;45412079
C= ] (rs429358 C and rs7412 C).12 Array genotyping of these single-nucleotide
polymorphisms is technically difﬁcult and, as a result, they are not available on
the majority of commercial arrays. single-nucleotide polymorphism genotypes
were thus obtained using Taqman technology at the Wellcome Trust Clinical
Research Facility Genetics Core, Edinburgh. Blood samples from GS:SFHS
participants were collected, processed and stored using standard operating
procedures and managed through a laboratory information management
system at the Wellcome Trust Clinical Research Facility Genetics Core,
Edinburgh.13
Ethics statement
All components of GS:SFHS received ethical approval from the NHS Tayside
Committee on Medical Research Ethics (REC Reference Number: 05/S1401/89).
GS:SFHS has also been granted Research Tissue Bank status by the Tayside
Committee on Medical Research Ethics (REC Reference Number: 10/S1402/20),
providing generic ethical approval for a wide range of uses within medical
research.
Cognition
Four cognitive ability domains were assessed in GS:SFHS – processing speed
(Wechsler Digit Symbol Substitution Test – DST14), verbal declarative memory
(Wechsler Logical Memory Test – LM; sum of immediate and delayed recall of
one paragraph15), verbal ﬂuency (the phonemic Verbal Fluency Test – VFT;
using the letters C, F, and L, each for 1 min16), and vocabulary (the Mill Hill
Vocabulary Scale –MHVS; junior and senior synonyms combined17). A general
cognitive ability factor, g, was obtained via a principal components analysis of
the four test scores. The ﬁrst unrotated principal, which explained 42% of the
variance, was extracted. All four tests loaded strongly on g (range 0.58–0.71).
Covariates
In addition to age and sex in the baseline models of APOE e4 status and
cognitive ability, sensitivity analyses were conducted that adjusted for potential
confounding and mediating variables. These included education, social class,
and self-reported heart disease, history of stroke, high blood pressure, diabetes,
AD, and depression. Education was recorded using an ordinal scale that ranged
from 0 to 10, where each value represented a 'bin' for different numbers of
years of full-time education (0, 1–4, 5–9, 10–11, 12–13, 14–15, 16–17, 18–19,
20–21, 22–23, ≥ 24 years). Social class was measured using the Scottish Index of
Multiple Deprivation 2009 (http://www.scotland.gov.uk/topics/statistics/simd/).
The Scottish Index of Multiple Deprivation ranks small areas of Scotland using
information on seven domains: income, employment, health, education,
geographic access, crime, and housing. The range of Scottish Index of Multiple
Deprivation ranks is from 1 (most deprived) to 6505 (least deprived).
Statistical analyses
Age-, and sex-adjusted linear mixed effects models of APOE against the
cognitive measures were performed for three different parameterisations of
APOE: e4 present versus absent; e4 dose – 0, 1, or 2 alleles; and APOE haplotype
– e2e2, e2e3, e2e4, e3e4, e4e4, with e3e3 as the reference level. Pedigree
information was used to deﬁne relatedness. Genetic relationships between
family members can be derived theoretically. For example, the genetic
correlation between parent–offspring pairs is 0.5, for grandparent–grand-
children it is 0.25, for ﬁrst cousins it is 0.12. A kinship matrix including this
information conditions the random additive genetic effect in the model.
To investigate age-stratiﬁed differences the cohort was split at 60 years to see
if there were differential effects of APOE in later life compared to mid-life. The
threshold of 60 years was chosen as an arbitrary cut-point for older age. A
continuous age – APOE interaction was also examined. Sensitivity analyses
adjusting for additional covariates were also performed. All models were run in
the statistical software package 'R', utilising the 'asreml' library.18,19 Wald tests
were used to calculate P-values.
Data availability
GS data are available at the European Genome-phenome Archive (https://www.
ebi.ac.uk/ega/home) under accession number EGAS00001001235.
RESULTS
Table 1 shows the characteristics of the GS:SFHS cohort. Of the 18 337
individuals (41% male) included in the analyses, the mean age was 47
(SD 15) years. The majority of the population carried two copies of
the e3 allele (n= 10 926, 60%) with 469 (2.6%) individuals having the
e4e4 haplotype and 111 (0.6%) having the e2e2 haplotype. The
proportions of e2e3, e2e4, and e3e4 haplotypes were 12.0%, 2.2%, and
23.1% (n= 2194, 411, 4226), respectively. There was very little
difference in the distribution of APOE alleles for those older than
60 years compared with those 60 or younger (Supplementary Table 1).
Table 1 Characteristics of the Generation Scotland: Scottish Family
Health Study cohort (n=18 337)
Mean SD
Age (years) 47.2 15.0
Educationa 4.7 1.6
Cognitive (number of correct items)
DST 72.3 171
VFT 39.8 11.7
MHVS 30.1 4.7
LM 31.1 7.9
Median IQR
SIMD 4342 2370–3910
n %
APOE
e2e2 111 0.6
e2e3 2194 12.0
e2e4 411 2.2
e3e3 10 926 59.6
e3e4 4226 23.1
e4e4 469 2.6
Sex (male) 7506 40.9
Heart disease (yes) 638 3.5
Stroke (yes) 232 1.3
High blood pressure (yes) 2421 13.2
Diabetes (yes) 570 3.1
Alzheimer's disease (yes) 23 0.1
Depression (yes) 1752 9.6
Abbreviations: DST, Digit Symbol Test; LM, logical memory; MHVS, Mill Hill Vocabulary Scale;
VFT, Verbal Fluency Test.
aEducation was measured as an ordinal variable (n=17687). 0: 0 years (n=7), 1: 1–4 years
(n=51), 2: 5–9 years (n=510), 3: 10–11 years (n=4781), 4: 12–13 years (n=3858),
5: 14–15 years (n=2594), 6: 16–17 years (n=3525), 7: 18–19 years (n=1727), 8: 20–21
years (n=445), 9: 22–23 years (n=127), 10: ≥24 years (n=62).
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The distributions of cognitive scores by APOE status are presented in
Supplementary Table 2.
Of the self-reported health variables, high blood pressure was the
most prevalent (13%), followed by depression (10%). The prevalences
of the other conditions were below 4% with only 23 (0.1%)
individuals reporting AD. The cross-sectional distributions of the four
cognitive tests by age are presented in Figure 1. There is marked
'decline' in scores on both the digit symbol and logical memory tasks
with age. The vocabulary measure 'increases' in early adulthood before
remaining relatively stable over the remainder of the life-course. There
is an inverted U-shaped pattern for verbal ﬂuency scores with lower
scores in young and late adulthood.
The output from the regression models are shown in Table 2.
Having two e4 alleles was associated with a one-point decrease
(standardised beta (β)=− 0.12, P= 0.007) in memory score relative
to individuals who had the e3e3 haplotype. Having either an e3e4 or
e4e4 haplotype was associated with around a one-point increase in the
measure of verbal ﬂuency (β= 0.064, P= 0.001, and β= 0.092,
P = 0.050, respectively). The e3e4 haplotype was also associated with
a very small increase in the vocabulary test score (β= 0.044, P= 0.015).
There was no evidence of any effect – protective or otherwise – of
having one or two e2 alleles (Supplementary Table 3). There were no
strong associations between g and APOE status other than a slightly
increased cognitive score for e4 carriers, which was more notable in the
younger (≤60 years) sub-population (Supplementary Table 4).
Table 3 presents analyses that stratiﬁed by age (≤60 years and
460). In the older subset of the cohort there was a pronounced effect
of the e4 allele on memory and processing speed with e4e4 carriers
Figure 1 Distribution of the four cognitive tests by age.
Table 2 Associations between APOE and cognitive ability adjusted for age and sex
Logical memory Verbal ﬂuency test Digit symbol test Mill Hill vocabulary scale
Beta SE P Beta SE P Beta SE P Beta SE P
e4 (additive) −0.027 0.015 0.067 0.055 0.015 o0.001 −0.014 0.013 0.288 0.036 0.014 0.011
e4 (yes vs no) −0.020 0.017 0.238 0.062 0.017 o0.001 −0.011 0.015 0.457 0.044 0.016 0.006
e2e2 −0.028 0.093 0.914 −0.024 0.094 0.745 −0.057 0.082 0.428 −0.029 0.088 0.633
e2e3 −0.039 0.023 0.181 −0.018 0.024 0.142 0.035 0.021 0.066 0.002 0.022 0.583
e2e4 −0.044 0.049 0.495 −0.025 0.050 0.294 −0.020 0.043 0.689 0.056 0.046 0.399
e3e4 −0.015 0.018 0.664 0.064 0.018 0.001 −0.0002 0.016 0.854 0.044 0.017 0.015
e3e3 — — — — — — — — — — — —
e4e4 −0.123 0.046 0.007 0.092 0.047 0.050 −0.048 0.041 0.233 0.036 0.044 0.405
Abbreviations: Beta, standardised beta; P, incremental P-value; SE, standard error. P-values o0.05 are highlighted in bold.
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scoring on average 2.6 and 4.2 points less, respectively, than e3e3
individuals on these tests (β=− 0.32, P= 0.003 and β=− 0.27,
P= 0.006). The e4 additive effects were associated with lower scores
on memory (0.8 points per allele, β=− 0.095, P= 0.003) and
processing speed (1.3 points per allele, β=− 0.087, P= 0.004); the
presence (versus absence) of the e4 allele was associated with similar
effect sizes. There were no signiﬁcant effects of e4 allele possession on
these test scores in the younger subset. Only those aged 60 years or
younger retained the association between the e3e4 (versus e3e3)
haplotype and improved verbal ﬂuency test scores and vocabulary.
The positive association between the e4e4 haplotype and verbal
ﬂuency persisted in the older age group, with an increased mean test
score of 2.7 points over those with the e3e3 haplotype (β= 0.232,
P= 0.034). The additive effect of the e4 allele on higher verbal ﬂuency
scores was seen in both sub-groups; the effect sizes for the presence
versus absence of the e4 allele were similar in both sub-groups but
were only signiﬁcant in the younger participants. Signiﬁcant additive
and presence versus absence effects of the e4 allele were only seen in
the younger sub-group for the vocabulary measure. The models that
investigated a continuous interaction between age and APOE status
yielded signiﬁcant ﬁndings for verbal ﬂuency only (Supplementary
Table 5). Test scores increased by 0.03 SDs for e4 carriers per
additional year (P= 0.034).
The sensitivity analyses that included full covariate adjustment made
little difference to the effect size estimates (Supplementary Tables 6
and 7). There was no association between the APOE e2 allele and any
of the cognitive test scores in an age- and sex-adjusted analysis
(Supplementary Table 2).
DISCUSSION
This study is the largest single analysis of APOE genotype and
cognition to date. For those over the age of 60, possession of the e4
allele was associated with lower memory and processing speed scores.
Conversely, across all age ranges, the e4 allele was associated with
improved performance on the test of verbal ﬂuency. There were also
modest associations between positive e4 carrier status and higher
vocabulary scores in the younger participants (o60). All of these
associations were retained after controlling for cardiovascular, mental
health, and demographic variables. There were no associations
between the APOE e2 allele and cognitive scores on any of the tests.
The main strengths of this study are its large sample size that
enabled us to detect relatively small effects, the cognitive battery testing
a number of domains, and wide age range, which allowed us to test for
moderation effects. Limitations include the cross-sectional nature of
the cognitive data, which restricted us to an analysis of APOE and a
range of cognitive abilities, but not cognitive decline.3,4 Other
limitations include the arbitrary cut-point of 60 years for the age
stratiﬁcation, which may obscure selectivity, eg, distribution of alleles.
However, despite the large sample size, there were relatively low
numbers of e2 and e4 carriers upon stratiﬁcation. The paucity of rare
allele carriers is also apparent from the results tables where sub-group
P-values are relatively modest.
Interpretation of the results is relatively straightforward for the
domains of memory and processing speed, where the e4 allele was
associated with lower test scores, which is in the same direction as
those previously reported.2 The positive association between the e4
allele and verbal ﬂuency scores ﬁts less well with the existing
literature.2 However, the distribution of the verbal ﬂuency scores in
Figure 1 is quite different to those for digit symbol and logical
memory. Indeed, it resembles more closely the 'crystallised'
vocabulary-based measure, which may explain the divergent ﬁndings
from the 'ﬂuid' tests, whose distributions mirror those previously
described.20 The small positive associations between the e4 allele and
vocabulary in the younger members of the cohort also support the
differential effects of APOE on crystallised-type and ﬂuid-type
measures of intelligence.
The magnitude of the effect sizes observed in the current study are
in line with those reported from a previous meta-analysis.2
Table 3 Age-stratiﬁed (460 and ≤60) associations between APOE and cognitive ability adjusted for age and sex
Logical memory Verbal ﬂuency test Digit symbol test Mill Hill vocabulary scale
Beta SE P Beta SE P Beta SE P Beta SE P
Age 460 years
e4 (additive) −0.095 0.033 0.003 0.075 0.033 0.023 −0.087 0.030 0.004 −0.026 0.033 0.423
e4 (yes vs no) −0.090 0.037 0.016 0.070 0.038 0.064 −0.082 0.034 0.017 −0.025 0.038 0.504
e2e2 0.075 0.225 0.614 −0.219 0.227 0.317 −0.205 0.206 0.352 0.020 0.224 0.928
e2e3 −0.079 0.051 0.326 −0.049 0.051 0.181 0.032 0.047 0.220 0.026 0.051 0.515
e2e4 −0.087 0.112 0.606 0.055 0.113 0.738 −0.079 0.103 0.583 −0.016 0.113 0.930
e3e4 −0.080 0.041 0.096 0.042 0.041 0.425 −0.057 0.038 0.219 −0.015 0.041 0.770
e3e3 — — — — — — — — — — — —
e4e4 −0.321 0.108 0.003 0.232 0.110 0.034 −0.272 0.100 0.006 −0.076 0.109 0.484
Age ≤60 years
e4 (additive) −0.013 0.016 0.425 0.044 0.016 0.008 −0.007 0.015 0.638 0.042 0.015 0.007
e4 (yes vs no) −0.006 0.019 0.748 0.054 0.019 0.004 −0.004 0.017 0.806 0.050 0.018 0.004
e2e2 −0.031 0.104 0.830 −0.020 0.104 0.769 −0.046 0.098 0.560 −0.048 0.097 0.534
e2e3 −0.023 0.026 0.443 −0.003 0.027 0.477 0.045 0.025 0.066 −0.006 0.025 0.350
e2e4 −0.033 0.055 0.597 −0.031 0.055 0.316 −0.031 0.051 0.527 0.070 0.051 0.305
e3e4 −0.0005 0.020 0.816 0.063 0.020 0.002 0.009 0.019 0.551 0.047 0.019 0.021
e3e3 — — — — — — — — — — — —
e4e4 −0.085 0.051 0.098 0.039 0.051 0.443 −0.031 0.048 0.522 0.050 0.048 0.296
Abbreviations: Beta, standardised beta; P, incremental P-value; SE, standard error. P-values o0.05 are highlighted in bold.
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The maximum standardised effect size in the current study for the e4
versus no e4 analysis, which is analogous to that reported by Wisdom
et al., was –0.09 for the association with memory in the older (460
years) sub-group for the logical memory test. The other effect sizes in
the older group were 0.07 (verbal ﬂuency), –0.08 (digit symbol), and –
0.03 (Mill Hill). In the younger group the effect sizes were 0.05 for
both verbal ﬂuency and Mill Hill, and –0.006 and –0.004 for logical
memory and digit symbol, respectively. The lack of any associations
between the APOE e2 allele and cognition is in accordance with the
meta-analysis ﬁndings of Wisdom, although the number of e3 carriers
in GS:SFHS was an order of magnitude greater than the equivalent
number in the meta-analysis.
In conclusion, we found negative associations between the APOE e4
allele and memory and processing speed in later life. The magnitude of
the effects is consistent with those previously reported. The e4 allele
was also linked to improved verbal ﬂuency, which goes against our a
priori hypothesis and some existing evidence, although this can
potentially be explained by the distribution of the scores, which
resemble more closely the shape of what one would expect from a
'crystallised'-type measure. There was no relationship between cogni-
tive performance and the APOE e2 allele.
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